Tatva Chintan Pharma Chem Limited: Financial Performance

*****Key Financial Highlights (Consolidated)***** * Revenue from Operations:Q2 FY27: Reached INR 2,173.20 million, up from INR 1,235.16 million in Q2 FY26. * H1 FY27: Stood at INR 3,843.75 million, compared to INR 2,403.80 million in H1 FY26. * Profit Before Tax (PBT):Q2 FY27: Reported at INR 289.40 million, compared to INR 136.63 million in Q2 FY26. * H1 FY27: Stood at INR 500.51 million, compared to INR 227.64 million in H1 FY26. * Net Profit / Profit for the Period:Q2 FY27: Recorded at INR 214.51 million, showing strong growth over INR 99.17 million in Q2 FY26. * H1 FY27: Stood at INR 374.32 million, up from INR 165.68 million in H1 FY26. * Earnings Per Share (EPS) (Face Value of INR 10 each - Not Annualised):Q2 FY27: Basic and Diluted EPS stood at INR 9.17, compared to INR 4.24 in Q2 FY26. * H1 FY27: Basic and Diluted EPS stood at INR 16.00, compared to INR 7.08 in H1 FY26. Disclosure /Disclaimer Link: *****